Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-02-02Clinical Trial Update: Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer [NA]
A clinical trial update from Fudan University investigates BRCA1/2 mutations and other potential genes in triple-negative breast cancer, wit…
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers [Phase 1]
Phase 1 study evaluating the safety and tolerability of combining everolimus with eribulin in patients with triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Huaier Granule in Treating Women With Triple Negative Breast Cancer [Phase 4]
Phase 4 clinical trial update evaluating Huaier Granule in women with triple-negative breast cancer. The trial status is listed as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer [Phase 2]
Open-label Phase 2 window-of-opportunity study evaluating ganetespib in women with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy [Phase 2]
Phase 2 clinical trial update evaluating BRCA1-associated DNA repair dysfunction in patients with early triple-negative breast cancer treate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-11-03Clinical Trial Update: Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer [Phase 3]
This update describes a Phase 3 trial evaluating zoledronic acid as adjuvant therapy for triple-negative breast cancer. The study is sponsor…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso [Phase 1]
Phase 1 study of CART-meso, a mesothelin-targeted CAR-T cell therapy, in patients with relapsed or chemotherapy-refractory advanced cancers,…
-
CLINICAL_TRIALS research · 2015-09-09Clinical Trial Update: Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients [Phase 2]
This is a completed Phase 2 study evaluating apatinib in patients with metastatic triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer [Phase 1]
Phase 1 trial evaluating RO4929097 with paclitaxel and carboplatin before surgery in stage II/III triple-negative breast cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
A completed clinical trial evaluating high-dose chemotherapy combined with adoptive dendritic cell-CIK cell therapy in patients with triple-…
-
CLINICAL_TRIALS research · 2015-07-22Clinical Trial Update: Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
This update notes the completed clinical trial evaluating chemotherapy with DC-CIK cell-based adoptive cellular therapy in triple-negative b…
-
CLINICAL_TRIALS withdrawal · 2015-06-22Clinical Trial Update: Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer [Phase 2]
A Phase 2 trial evaluating allogeneic hematopoietic cell transplantation for patients with refractory triple-negative breast cancer has been…
-
CLINICAL_TRIALS research · 2015-06-08Clinical Trial Update: Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer [NA]
This document provides an update on a clinical trial studying breast-conserving therapy for patients with triple-negative breast cancer; the…
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update evaluating veliparib in combination with carboplatin and paclitaxel for locally advanced or metastatic solid tumors. Th…
-
CLINICAL_TRIALS withdrawal · 2015-04-27Clinical Trial Update: LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating LDE225 (sonidegib) for stage II-III estrogen receptor- and HER2-negative breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery [Phase 1]
A phase 1 trial of RO4929097 and vismodegib for metastatic or unresectable breast cancer was terminated; no results are reported in this upd…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating paclitaxel with or without carboplatin and/or bevacizumab, followed by doxorubicin and cyclophosphamide, in patie…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC) [Phase 3]
Phase 3 trial comparing gemcitabine plus cisplatin vs gemcitabine plus paclitaxel in triple-negative breast cancer has completed. The record…
-
CLINICAL_TRIALS research · 2015-03-18Clinical Trial Update: Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
This clinical trial investigates whether tumor suppressor gene status can predict chemotherapy response in triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer [Phase 2]
Phase II results update for a capecitabine and cisplatin regimen in metastatic triple-negative breast cancer. The results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer [Phase 2]
Phase II trial of Abraxane, Avastin (bevacizumab), and carboplatin in triple-negative metastatic breast cancer completed; results were poste…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update of NK012 in advanced, metastatic triple-negative breast cancer has completed enrollment and analysis.
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: AR-inhibitor Bicalutamide in Treating Patients With TNBC [Phase 2]
Phase 2 trial investigating the AR inhibitor bicalutamide for triple-negative breast cancer; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Re-expression of ER in Triple Negative Breast Cancers [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial evaluating re-expression of the estrogen receptor in triple-negative breast cancer. The s…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Triple Negative Breast Cancer: Study of Molecular and Genetic Factors [NA]
Clinical trial update describing a study of molecular and genetic factors in triple-negative breast cancer; the trial status is unknown.